Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 26;22(11):5683.
doi: 10.3390/ijms22115683.

Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected

Affiliations
Review

Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected

Irina V Bure et al. Int J Mol Sci. .

Abstract

Despite recent progress, gastric cancer remains one of the most common cancers and has a high mortality rate worldwide. Aberrant DNA methylation pattern and deregulation of noncoding RNA expression appear in the early stages of gastric cancer. Numerous investigations have confirmed their significant role in gastric cancer tumorigenesis and their high potential as diagnostic and prognostic biomarkers. Currently, it is clear that these epigenetic regulators do not work alone but interact with each other, generating a complex network. The aim of our review was to summarize the current knowledge of this interaction in gastric cancer and estimate its clinical potential for the diagnosis, prognosis, and treatment of the disease.

Keywords: DNA methylation; biomarker; epigenetics; gastric cancer; noncoding RNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The interplay between DNA methylation and ncRNAs in GC epigenetic regulation. GC—gastric cancer; EMT—epithelial–mesenchymal transition; arrows—activation; bars—suppression.

Similar articles

Cited by

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Sitarz R., Skierucha M., Mielko J., Offerhaus J., Maciejewski R., Polkowski W. Gastric cancer: Epidemiology, prevention, classification, and treatment. Cancer Manag. Res. 2018;10:239–248. doi: 10.2147/CMAR.S149619. - DOI - PMC - PubMed
    1. Necula L., Matei L., Dragu D., Neagu A.I., Mambet C., Nedeianu S., Bleotu C., Diaconu C.C., Chivu-Economescu M. Recent advances in gastric cancer early diagnosis. World J. Gastroenterol. 2019;25:2029–2044. doi: 10.3748/wjg.v25.i17.2029. - DOI - PMC - PubMed
    1. Zhou Z., Lin Z., Pang X., Tariq M.A., Ao X., Li P., Wang J. Epigenetic regulation of long non-coding RNAs in gastric cancer. Oncotarget. 2017;9:19443–19458. doi: 10.18632/oncotarget.23821. - DOI - PMC - PubMed
    1. Maruyama R., Suzuki H., Yamamoto E., Imai K., Shinomura Y. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumor Biol. 2012;33:277–285. doi: 10.1007/s13277-011-0308-9. - DOI - PubMed